MARKET NEWS

English
Specials
Moneycontrol Be a PRO
you are here:
Success
Alert
Please select a Day.
Info
Open Trading Account

Divis Laboratories Ltd.

Sector: Pharmaceuticals
Add to
3,821.85
38.45 (1.02%)

As on 16 Apr, 2021 | 03:59

Trade
Day Range
3733.40
3845.00
L H
52 Week Range
2090.05
3914.95
L H
Volume
681,099
*
i

* BSE Market Depth (16 Apr 2021)

BUY SELL
QTY PRICE PRICE QTY
1 3811.00 3818.00 9
5 3810.00 3825.00 11
5 3798.40 3830.00 16
5 3783.00 3831.00 3
4 3774.00 3833.00 1
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
3,823.70
40.75 (1.08%)

As on 16 Apr, 2021 | 04:00

Day Range
3734.85
3844.00
L H
52 Week Range
2094.60
3913.00
L H
Volume
21,130
*
i

* BSE Market Depth (16 Apr 2021)

BUY SELL
QTY PRICE PRICE QTY
1 3811.00 3818.00 9
5 3810.00 3825.00 11
5 3798.40 3830.00 16
5 3783.00 3831.00 3
4 3774.00 3833.00 1
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
--
-- (--%)

As on --

Day Range
--
--
L H
Open Interest Analysis
Long Unwinding

(OI , PRICE )

See Historical Trend

Volume
--
Advance Chart
--
-- (--%)

As on --

Day Range
--
--
L H
Moneyness
--
Volume
--
Advance Chart
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
MC Essentials
81% Pass
MC Technicals
 Trend
i
This represents current trend.Click here for disclaimer.
MC Insights

Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

Financials
    Ownerships
      Industry Comparison
        Others
          Powered by Powered by Trendlyne
          Open3,790.00
          Previous Close3,783.40
          UC Limit4,161.70
          LC Limit3,405.10
          Volume681,099.00
          VWAP3,798.49
          Mkt Cap (Rs. Cr.)101,458
          20D Avg Volume815,737
          20D Avg Delivery356,360
          Beta0.480.41
          Face Value2.00
          TTM EPS70.46
          TTM PE54.24
          Sector PE40.55
          Book Value Per Share275.36
          P/B13.88
          Dividend Yield0.42
          P/C49.33

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 82.86% away from 52 week low
          • 2.38% away from 52 week high
          • Outperformer - Divis Laboratories up by 13.13% v/s NIFTY 50 down by -1.96% in last 1 month
          • F&O data suggests Short Covering today
          • Stock saw 8 number of Large Deals today.Tap to see details.
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          6

          indicates Average Financials

          3 year CAGR growth
          Revenue 10.5%
          NetProfit 9.1%
          OperatingProfit 8.0%
          Industry Comparison
          • TTM PE Ratio - High in industry
          • Market Cap - Market Runner Up
          • Price to Book Ratio - High in industry
          • TTM PEG Ratio - High in industry
          Shareholding Pattern
          • Promoters holding remains unchanged at 51.95% in Mar 2021 qtr
          • Mutual Funds have decreased holdings from 13.19% to 12.59% in Mar 2021 qtr
          • Number of MF schemes remains unchanged at 36 in Mar 2021 qtr
          • FII/FPI have decreased holdings from 20.37% to 19.87% in Mar 2021 qtr
          • Number of FII/FPI investors remains unchanged at 806 in Mar 2021 qtr
          • Institutional Investors have decreased holdings from 37.23% to 36.61% in Mar 2021 qtr
          Powered by Powered by Trendlyne

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis

          Forum

          Community Sentiments

          • 91% BUY
          • 9% SELL
          • 0% HOLD
          91%
          of moneycontrol users recommend buying Divis Labs

          What's your call on Divis Labs today?

          Read 18 investor views

          BUY SELL HOLD
          POST

          Broker Research

          23 Mar, 2021

          Sharekhan

          Reco Price 3493.65 Target Price 4500
          04 Dec, 2020

          Sharekhan

          Reco Price 3711.35 Target Price 4175
          06 Nov, 2020

          Sharekhan

          Reco Price 3237.70 Target Price 3800
          Show More
          Thomson Reuters Report

          Deals

          08 Apr, 2021

          THE MTBJ LTD. AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849

          Qty 61997 Price 3698.85 % Traded 0.02
          08 Apr, 2021

          THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794

          Qty 61997 Price 3698.85 % Traded 0.02
          25 Feb, 2021

          VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II

          Qty 36016 Price 3486.65 % Traded 0.01
          25 Feb, 2021

          VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND

          Qty 36016 Price 3486.65 % Traded 0.01
          14 Jan, 2021

          VFTR C INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II

          Qty 35151 Price 3718.9 % Traded 0.01
          14 Jan, 2021

          VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND

          Qty 35151 Price 3718.9 % Traded 0.01
          29 Mar, 2017

          VALIANT MAURITIUS PARTNERS LIMITED

          Qty 1129113 Price 635 % Traded 0.43
          29 Mar, 2017

          CREDIT SUISSE (SINGAPORE) LIMITED A/C CREDIT SUISSE (SINGAP

          Qty 1129113 Price 635 % Traded 0.43

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          + Show More
          30 Nov, 2018

          INTEGRATED CORE STRATEGIES (ASIA) PTE.LTD.

          Qty 1886001 Price 1438.98 % Traded 0.71
          31 May, 2018

          BLACKROCK INDIA EQUITIES FUND (MAURITIUS) LIMITED

          Qty 1454375 Price 1047.17 % Traded 0.55
          31 May, 2017

          INTEGRATED CORE STRATEGIES (ASIA) PTE.LTD.

          Qty 2285198 Price 582.12 % Traded 0.86
          31 May, 2017

          BARCLAYS GLOBAL FUND ADVISORS A/C ISHARES INDIA MAURITIUS C

          Qty 2373622 Price 582.9 % Traded 0.89
          30 Nov, 2012

          VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VANG

          Qty 955020 Price 1194.11 % Traded 0.36
          30 Nov, 2012

          BARCLAYS GLOBAL FUND ADVISORS A/C ISHARES INDIA MAURITIUS C

          Qty 698683 Price 1188.73 % Traded 0.26

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          + Show More
          Powered by Powered by Trendlyne

          Insider Transaction Summary

          Apr, 01, 2021

          Y.Venkateswara Rao

          Designated Person
          Qty 1000 Price 3575.02 % Traded 0.00 Post Tnx Hold. 0%
          Apr, 01, 2021

          Y.Venkateswara Rao

          Designated Person
          Qty 500 Price 3604.74 % Traded 0.00 Post Tnx Hold. 0%
          Mar, 30, 2021

          Y. Rama Devi

          Employees Immediate Relative
          Qty 400 Price 3507.25 % Traded 0.00 Post Tnx Hold. 0%
          Mar, 26, 2021

          S Rama Krishna

          Designated Person
          Qty 2800 Price 3405.95 % Traded 0.00 Post Tnx Hold. 0.01%
          Mar, 25, 2021

          Sirisha Mandava

          Designated Person
          Qty 2000 Price 3450 % Traded 0.00 Post Tnx Hold. 0%
          Mar, 25, 2021

          S Rama Krishna

          Designated Person
          Qty 36800 Price 3528.1 % Traded 0.01 Post Tnx Hold. 0.01%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Show All Transactions
          Mar, 15, 2019

          Reliance Nippon Life Asset Management Ltd

          Other
          Qty 83580 Price 0 % Traded 0.03 Post Tnx Hold. 3.01%
          Oct, 31, 2018

          Divi Satchandra Kiran

          Promoter
          Qty 8000000 Price 0 % Traded 3.01 Post Tnx Hold. 20.34%
          Oct, 31, 2018

          Murali Krishna Prasad Divi

          Promoter
          Qty 8000000 Price 0 % Traded 3.01 Post Tnx Hold. 2.85%
          Jul, 10, 2017

          SBI Mutual Fund

          null
          Qty 188637 Price 0 % Traded 0.07 Post Tnx Hold. 5.05%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend
          Insights
          Institutional Holder Analysis Total Number Change Total Holding (%) Change
          MF Schemes (Mar 2021) 36 0 12.59 -0.6
          FII/FPI (Mar 2021) 710 -6 19.87 -0.5

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Divis Labs 3821.85 1.02 101458.11 54.24 13.88 18.83 59.70 1,376 5,394 0.00
          Sun Pharma 646.05 2.02 155009.04 60.49 3.16 8.31 39.32 4,186 32,837 0.17
          Dr Reddys Labs 4893.25 0.98 81375.35 37.41 5.22 12.98 26.75 1,969 17,517 0.11
          Cipla 938.05 2.61 75650.29 33.82 4.73 9.81 56.22 1,546 17,131 0.18
          Aurobindo Pharm 953.00 4.12 55839.95 10.37 3.32 16.84 74.97 2,844 23,098 0.32
          + See More

          About the Company

          DiviS Laboratories Ltd is engaged in the manufacture of Active Pharma Ingredients (APIs) and intermediates. The company in a matter of short time expanded their breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.They are actively involved in developing alternate, patent non-infringing processes for APIs, for the inventors to manage late life cycle and leading generic drug manufacturers.The company`s product range includes Bupropion Hbr,Bupropion HCL,Capecitabine,Carbidopa,Desloratadine,Dexlansoprazole /(R)-Lansoprazole,Irbesartan,Levodopa,Niacin,Sibutramine HCL,Valacyclovir HCL,Valsartan,Venlafaxine HCL,VerapamiL HCL,Vigabatrin,Zolpidem Tartrate ,etc
          {"success":1,"data":{"address":{"address1":"Divi Towers,","address2":"1-72\/23(P)\/DIVIS\/303,,Cyber Hills, Gachibowli,","city":"Hyderabad","state":"Telangana","pincode":"500032","telephone1":"040-23786300","telephone2":"","fax1":"040-23786460","fax2":"","email":"mail@divislabs.com","web":"http:\/\/www.divislabs.com"},"management":[{"name":"Ramesh B V Nimmagadda","designation":"Non Executive Chairman"},{"name":"Murali K Divi","designation":"Managing Director"},{"name":"Madhusudana Rao Divi","designation":"Whole Time Director"},{"name":"Satchandra Kiran Divi","designation":"WholeTime Director & CEO"},{"name":"Nilima Motaparti","designation":"Whole Time Director"}],"registrars":{"name":"Karvy Computershare Private Ltd.","address1":"Karvy Selenium Tower B","address2":"Plot no. 31-32, Gachibowli","address3":"Financial District","address4":"Nanakramguda","telephone":"040-23001153","fax":"","email":"","internet":"","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"Yes"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"532488","nseId":"DIVISLAB","series":"EQ","isinid":"INE361B01024"}}}

          • Registered Office

            • Address

              Divi Towers,,1-72/23(P)/DIVIS/303,,Cyber Hills, Gachibowli,

            • City

              Hyderabad

            • State

              Telangana

            • Pin Code

              500032

            • Tel. No.

              040-23786300

            • Fax No.

              040-23786460

            • Email

              mail@divislabs.com

            • Internet

              http://www.divislabs.com

          • Registrars

            • Address

              Karvy Selenium Tower B,Plot no. 31-32, Gachibowli

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-23001153

            • Fax No.

            • Email

            • Internet

          • Management

            • Ramesh B V Nimmagadda

              Non Executive Chairman

            • Murali K Divi

              Managing Director

            • Madhusudana Rao Divi

              Whole Time Director

            • Satchandra Kiran Divi

              WholeTime Director & CEO

            • Nilima Motaparti

              Whole Time Director

            + See More

          • Included In

            • BSE 100

              Yes

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              Yes

            • BSE 500

              Yes

          • Details

            • BSE:

              532488

            • NSE:

              DIVISLAB

            • Series

              EQ

            • ISIN

              INE361B01024

          Go to Top

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>

          Sections
          Desktop Version »
          Follow us on
          Facebook Twitter Instagram Teglegram Jio News
          Available On
          Download from Google Play Download from App Stoer Download from Windows Phone
          Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us
          Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

          Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.